<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05068063</url>
  </required_header>
  <id_info>
    <org_study_id>IPACK1</org_study_id>
    <nct_id>NCT05068063</nct_id>
  </id_info>
  <brief_title>Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia</brief_title>
  <official_title>A Randomised Comparison Between Combined Femoral Triangle Block+IPACK Block and Femoral Triangle Block for Anterior Cruciate Ligament Reconstruction Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinica Alemana de Santiago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An adequate balance between analgesia and motor function is an essential requirement to&#xD;
      facilitate functional recovery and early discharge after anterior cruciate ligament (ACL)&#xD;
      reconstruction surgery.&#xD;
&#xD;
      Proximal nerve blocks (i.e. femoral and sciatic nerve blocks) are associated with optimal&#xD;
      analgesia, but they can cause muscle weakness, interfering with rehabilitation and increasing&#xD;
      the risk of falls .&#xD;
&#xD;
      A recent randomized controlled trial concluded that, compared to mid-and distal ACB, a distal&#xD;
      femoral triangle block (FTB) is associated with lower opioid consumption and improved&#xD;
      postoperative analgesia for ambulatory ACL reconstruction.&#xD;
&#xD;
      In ACL reconstruction surgery there are other potential sources of pain not covered by a FTB,&#xD;
      such as intra-articular structures (menisci, cruciate ligaments), posterior knee capsule and&#xD;
      the graft donor site.&#xD;
&#xD;
      Evidence supporting the addition of an IPACK block to a FTB has been studied for patients&#xD;
      undergoing total knee replacement, nonetheless, there is no trial analyzing the analgesic&#xD;
      contribution of IPACK to a FTB in the context of ACL reconstruction surgery.&#xD;
&#xD;
      In this multicentric trial, the investigators set out to analyze the analgesic benefit of&#xD;
      adding an IPACK block to a FTB.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 30, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain scores at 2 hours of arrival to Post Anesthesia Care Unit (PACU)</measure>
    <time_frame>2 hours after arrival to PACU</time_frame>
    <description>Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative static pain scores at 0 hours of arrival to PACU</measure>
    <time_frame>0 hours after arrival to PACU</time_frame>
    <description>Pain evaluated at rest in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative static pain scores at PACU discharge</measure>
    <time_frame>at discharge of PACU up to 2 hours postoperatively</time_frame>
    <description>Pain evaluated at rest in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative static pain scores at 6 hours of arrival to PACU</measure>
    <time_frame>6 hours after arrival to PACU</time_frame>
    <description>Pain evaluated at rest in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative static pain scores at 12 hours of arrival to PACU</measure>
    <time_frame>12 hours after arrival to PACU</time_frame>
    <description>Pain evaluated at rest in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative static pain scores at 24 hours of arrival to PACU</measure>
    <time_frame>24 hours after arrival to PACU</time_frame>
    <description>Pain evaluated at rest in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative dynamic pain scores at 0 hours of arrival to PACU</measure>
    <time_frame>0 hours after arrival to PACU</time_frame>
    <description>Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative dynamic pain scores at PACU discharge</measure>
    <time_frame>at discharge of PACU up to 2 hours postoperatively</time_frame>
    <description>Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative dynamic pain scores at 6 hours of arrival to PACU</measure>
    <time_frame>6 hours after arrival to PACU</time_frame>
    <description>Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative dynamic pain scores at 12 hours of arrival to PACU</measure>
    <time_frame>12 hours after arrival to PACU</time_frame>
    <description>Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative dynamic pain scores at 24 hours of arrival to PACU</measure>
    <time_frame>24 hours after arrival to PACU</time_frame>
    <description>Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Femoral Triangle Block success assessment at 2 hours</measure>
    <time_frame>2 hours after arrival to PACU</time_frame>
    <description>Sensory block will be assessed with ice on the medial leg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of opioid related adverse events</measure>
    <time_frame>24 hours after arrival to PACU</time_frame>
    <description>Incidence of adverse events related to opioid use (nausea/vomiting, pruritus, somnolence, respiratory depression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative opioid consumption</measure>
    <time_frame>From anesthesia induction to extubation</time_frame>
    <description>Total opioid use during intraoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACU opioid consumption</measure>
    <time_frame>from PACU arrival to discharge up to 2 hours postoperatively</time_frame>
    <description>total opioid consumption during PACU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid consumption</measure>
    <time_frame>6 hours, 12 hours and 24 hours after PACU arrival</time_frame>
    <description>Total opioid consumption</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Anterior Cruciate Ligament Rupture</condition>
  <condition>Acute Pain</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Knee Injuries</condition>
  <arm_group>
    <arm_group_label>Femoral Triangle + IPACK block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to receive a combination of femoral triangle block and active IPACK block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral Triangle block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to receive a combination of femoral triangle block and sham IPACK block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Injection</intervention_name>
    <description>Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of Bupivacaine 0.25%</description>
    <arm_group_label>Femoral Triangle + IPACK block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal Saline</intervention_name>
    <description>Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of normal saline 0.9%</description>
    <arm_group_label>Femoral Triangle block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient scheduled to undergo anterior cruciate ligament reconstruction under general&#xD;
             anesthesia with ipsilateral autologous graft.&#xD;
&#xD;
          -  Age between 18 and 65 years&#xD;
&#xD;
          -  American Society of Anesthesiologists classification 1-3&#xD;
&#xD;
          -  Body mass index between 19 and 35 (kg/m2)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults who are unable to give their own consent&#xD;
&#xD;
          -  Pre-existing neuropathy (assessed by history and physical examination)&#xD;
&#xD;
          -  Coagulopathy (assessed by history and physical examination and, if deemed clinically&#xD;
             necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4&#xD;
             or prothrombin time ≥ 50)&#xD;
&#xD;
          -  Renal failure (assessed by history and physical examination and, if deemed clinically&#xD;
             necessary, by blood work up i.e. creatinine ≥ 100)&#xD;
&#xD;
          -  Hepatic failure (assessed by history and physical examination and, if deemed&#xD;
             clinically necessary, by blood work up i.e. transaminases ≥ 100)&#xD;
&#xD;
          -  Allergy to local anesthetics (LAs), morphine or tramadol&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  ACL revision surgery&#xD;
&#xD;
          -  Contralateral graft or any type of allograft&#xD;
&#xD;
          -  Chronic pain syndromes requiring opioid intake at home&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Gonzalez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Alemana de Santiago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastian L Layera, MD</last_name>
    <phone>+562 29788221</phone>
    <email>sebastianlayera@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julian Aliste, MD</last_name>
    <phone>+562 29788221</phone>
    <email>julian.aliste@uchile.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinica Alemana de Santiago</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <country>Chile</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrea Gonzalez, MD</last_name>
      <phone>+562 2210 1111</phone>
      <email>andreagonzalezsegovia@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universidad de Chile</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <country>Chile</country>
      </address>
    </facility>
    <contact>
      <last_name>Sebastian L Layera, MD</last_name>
      <phone>+562 29788221</phone>
      <email>sebastianlayera@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <reference>
    <citation>Wilde J, Bedi A, Altchek DW. Revision anterior cruciate ligament reconstruction. Sports Health. 2014 Nov;6(6):504-18. doi: 10.1177/1941738113500910.</citation>
    <PMID>25364483</PMID>
  </reference>
  <reference>
    <citation>Sharma S, Iorio R, Specht LM, Davies-Lepie S, Healy WL. Complications of femoral nerve block for total knee arthroplasty. Clin Orthop Relat Res. 2010 Jan;468(1):135-40. doi: 10.1007/s11999-009-1025-1. Epub 2009 Aug 13.</citation>
    <PMID>19680735</PMID>
  </reference>
  <reference>
    <citation>Abdallah FW, Whelan DB, Chan VW, Prasad GA, Endersby RV, Theodoropolous J, Oldfield S, Oh J, Brull R. Adductor Canal Block Provides Noninferior Analgesia and Superior Quadriceps Strength Compared with Femoral Nerve Block in Anterior Cruciate Ligament Reconstruction. Anesthesiology. 2016 May;124(5):1053-64. doi: 10.1097/ALN.0000000000001045.</citation>
    <PMID>26938989</PMID>
  </reference>
  <reference>
    <citation>Abdallah FW, Mejia J, Prasad GA, Moga R, Chahal J, Theodoropulos J, Dwyer T, Brull R. Opioid- and Motor-sparing with Proximal, Mid-, and Distal Locations for Adductor Canal Block in Anterior Cruciate Ligament Reconstruction: A Randomized Clinical Trial. Anesthesiology. 2019 Sep;131(3):619-629. doi: 10.1097/ALN.0000000000002817.</citation>
    <PMID>31246607</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Pedersen EM, Børglum J. Redefining the adductor canal block. Reg Anesth Pain Med. 2014 Sep-Oct;39(5):442-3. doi: 10.1097/AAP.0000000000000119.</citation>
    <PMID>25140514</PMID>
  </reference>
  <reference>
    <citation>Johnston DF, Sondekoppam RV, Uppal V, Litchfield R, Giffin R, Ganapathy S. Effect of combining peri-hamstring injection or anterior obturator nerve block on the analgesic efficacy of adductor canal block for anterior cruciate ligament reconstruction: a randomised controlled trial. Br J Anaesth. 2020 Mar;124(3):299-307. doi: 10.1016/j.bja.2019.11.032. Epub 2020 Jan 21.</citation>
    <PMID>31980156</PMID>
  </reference>
  <reference>
    <citation>Johnston DF, Black ND, Cowden R, Turbitt L, Taylor S. Spread of dye injectate in the distal femoral triangle versus the distal adductor canal: a cadaveric study. Reg Anesth Pain Med. 2019 Jan;44(1):39-45. doi: 10.1136/rapm-2018-000002.</citation>
    <PMID>30640651</PMID>
  </reference>
  <reference>
    <citation>Chan E, Howle R, Onwochei D, Desai N. Infiltration between the popliteal artery and the capsule of the knee (IPACK) block in knee surgery: a narrative review. Reg Anesth Pain Med. 2021 Sep;46(9):784-805. doi: 10.1136/rapm-2021-102681. Epub 2021 May 14. Review.</citation>
    <PMID>33990439</PMID>
  </reference>
  <reference>
    <citation>Bushnell BD, Sakryd G, Noonan TJ. Hamstring donor-site block: evaluation of pain control after anterior cruciate ligament reconstruction. Arthroscopy. 2010 Jul;26(7):894-900. doi: 10.1016/j.arthro.2009.11.022. Epub 2010 May 13.</citation>
    <PMID>20620788</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Chile</investigator_affiliation>
    <investigator_full_name>Sebastian Layera</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>nerve block</keyword>
  <keyword>IPACK</keyword>
  <keyword>femoral triangle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

